NTRA Q3 2025 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$592M+34.7% YoY

Gross Profit

$384M64.9% margin

Operating Income

-$98M-16.5% margin

Net Income

-$88M-14.8% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+8.3%

Cash Flow

Operating Cash Flow

$59M

Free Cash Flow

$24M

Stock-Based Comp.

$91M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$569M

Stockholders' Equity

$1.3B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$592M	$440M	+34.7%
Gross Profit	$384M	$272M	+41.4%
Operating Income	-$98M	-$39M	-148.0%
Net Income	-$88M	-$32M	-177.1%

Revenue Segments

Product

$590M100%

Licensing and other

$2M0%

Geographic Segments

United States

$582M98%

Europe, Middle East, India, Africa

$6M1%

Asia Pacific and Other

$2M0%

Americas, excluding U.S.

$2M0%